Catalyst Intel Subscribe

Trial results

$IRD — OPGx-LCA5

Opus Genetics, Inc. (IRD) OPGx-LCA5: trial results in LCA5-associated inherited retinal disease, 2027.

Research by Catalyst Intel

Event id
IRD-OPGXLCA5-2026
Company
Opus Genetics, Inc.
Kind
Trial results
Indication
LCA5-associated inherited retinal disease
Window
2027-01-01 – 2027-12-31
Status
dropped

The bar

No bar has been published for this event yet.

Verdicts

No verdict has been published for this event yet.